Abstract
Neurologic issues usually accompany diabetes mellitus, which can be incapacitating. Diabetic patients may have discomfort and sensory anomalies, weakness and paralysis, and symptoms of autonomic dysfunction. Neurological problems have been linked to diabetes mellitus for many years, but our understanding of this group of ailments is exceedingly restricted. Diabetes type 2 is a metabolic disorder characterized by hyperglycemia, dyslipidemia, and insulin resistance. Strokes, vascular dementia, and Alzheimer’s have been associated with it. Pathologic examinations are ambiguous and incomplete. It is challenging to develop a diagnosis and interpret a pathophysiologic pattern given the vast range of clinical symptoms. Many studies have looked at the potential causes of various diseases, but none have addressed the core problem. Despite significant advancements in our knowledge of neurological problems and diabetes over the past 10 years, it is still unclear which specific pathways cause type 1 and type 2 diabetes-related neurological abnormalities. Future research on disease causation will be essential for dealing with diabetic neuropathy on all fronts, from prevention to therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akter, S., Goto, A., & Mizoue, T. (2017). Smoking and the risk of type 2 diabetes in Japan: A systematic review and meta-analysis. Journal of Epidemiology, 27(12), 553–561.
Allen, K. V., Frier, B. M., & Strachan, M. W. J. (2004). The relationship between type 2 diabetes and cognitive dysfunction: Longitudinal studies and their methodological limitations. European Journal of Pharmacology, 490, 169–175.
American Diabetes Association. (2008). Economic costs of diabetes in the U.S. in 2007. Diabetes Care, 31(3), 596–615.
American Diabetes Association. (2009). Diagnosis and classification of diabetes mellitus. Diabetes Care, 32(Suppl 1), S62–S67.
American Diabetes Association. (2014). Diagnosis and classification of diabetes mellitus. Diabetes Care, 37(SUPPL.1), S81–S90.
Awad, N., Gagnon, M., & Messier, C. (2004). The relationship between impaired glucose tolerances, type 2 diabetes, and cognitive function. Journal of Clinical and Experimental Neuropsychology, 26, 1044–1080.
Awotidebe TO, Ativie, R. N., Oke, K. I., et al. (2016). Relationships among exercise capacity, dynamic balance and gait characteristics of Nigerian patients with type - 2 diabetes: An indication for fall prevention. Journal of Exercise Rehabilitation, 12(6), 581–588.
Bădescu, S., Tătaru, C., Kobylinska, L., Georgescu, E. L., Zahiu, D. M., Zăgrean, A. M., & Zăgrean, L. (2016). The association between diabetes mellitus and depression. Journal of Medicine and Life, 9, 120–125.
Beydoun, M. A., & Wang, Y. (2010). Pathways linking socioeconomic status to obesity through depression and lifestyle factors among young US adults. Journal of Affective Disorders, 123, 52–63. https://doi.org/10.1016/j.jad.2009.09.021
Bien, C. G., & Scheffer, I. E. (2011). Autoantibodies and epilepsy. Epilepsia, 52(Suppl 3), 18–22.
Bromet, E., Andrade, L. H., Hwang, I., et al. (2011). Cross-national epidemiology of DSM-IV major depressive episode. BMC Medicine, 9, 90. https://doi.org/10.1186/1741-7015-9-90
Champaneri, S., Wand, G. S., Malhotra, S. S., Casagrande, S. S., & Golden, S. H. (2010). Biological basis of depression in adults with diabetes. Current Diabetes Reports, 10, 396–405. https://doi.org/10.1007/s11892-010-0148-9
Chang, Y. H., Ho, W. C., Tsai, J. J., Li, C. Y., & Lu, T. H. (2012). Risk of mortality among patients with epilepsy in southern Taiwan. Seizure, 21, 254–259.
Chen, R., Ovbiagele, B., & Feng, W. (2016 Apr 1). Diabetes and stroke: Epidemiology, pathophysiology, pharmaceuticals and outcomes. The American Journal of the Medical Sciences, 351(4), 380–386.
Chen, G., Xu, R., Wang, Y., et al. (2012). Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy. American Journal of Physiology - Endocrinology and Metabolism, 303, E563–E575. https://doi.org/10.1152/ajpendo.00591.2011
Chockalingam, A., Natarajan, P., Thanikachalam, P., & Pandiyan, R. (2021 Mar). Insulin resistance: The inconvenient truth. Missouri Medicine, 118(2), 119.
Chou, I. C., Wang, C. H., Lin, W. D., Tsai, F. J., Lin, C. C., & Kao, C. H. (2016). Risk of epilepsy in type 1 diabetes mellitus: A population-based cohort study. Diabetologia, 59, 1196–1203.
Dafoulas, G. E., Toulis, K. A., McCorry, D., Kumarendran, B., Thomas, G. N., Willis, B. H., et al. (2017). Type 1 diabetes mellitus and risk of incident epilepsy: A population-based, open-cohort study. Diabetologia, 60, 258–261.
Dardano, A., Penno, G., Prato, S. D., & Miccoli, R. (2014). Optimal therapy of type 2 diabetes: A controversial challenge. Aging, 6(3), 187–206.
de Kloet, E. R., Jöels, M., & Holsboer, F. (2005). Stress and the brain: From adaptation to disease. Nature Reviews. Neuroscience, 6(6), 463–475.
deJoode, J. W., van Dijk, S. E., Walburg, F. S., et al. (2019). Diagnostic accuracy of depression questionnaires in adult patients with diabetes: A systematic review and meta-analysis. PLoS One, 14, e0218512. https://doi.org/10.1371/journal.pone.0218512
Dickerson, S., & Kemeny, M. (2004). Acute stressors and cortisol responses: A theoretical integration and synthesis of laboratory research. Psychological Bulletin, 130, 355–391.
Dumbell, R., Matveeva, O., & Oster, H. (2016). Circadian clocks, stress, and immunity. Frontiers in Endocrinology, 7, 37.
Epel, E. S., Crosswell, A. D., Mayer, S. E., Prather, A. A., Slavich, G. M., Puterman, E., & Mendes, W. B. (2018). More than a feeling: A unified view of stress measurement for population science. Frontiers in Neuroendocrinology Stress Brain, 49, 146–169.
Esiri, M. M., Matthews, F., Brayne, C., & Neuropathology Group. Medical Research Council Cognitive Function and Aging Study; Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). (2001). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet, 357(9251), 169–175.
Ferlazzo, E., Gasparini, S., Beghi, E., Sueri, C., Russo, E., Leo, A., et al. (2016). Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors. Epilepsia, 57, 1205–1214.
Frier, B. M. (2014). Hypoglycaemia in diabetes mellitus: Epidemiology and clinical implications. Nature Reviews. Endocrinology, 10, 711–722.
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences, 21, 6275.
Gispen, W. H., & Biessels, G. J. (2000). Cognition and synaptic plasticity in diabetes mellitus. Trends in Neurosciences, 23, 542–549.
Gold, S. M., Dziobek, I., Sweat, V., et al. (2007). Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia, 50, 711–719. https://doi.org/10.1007/s00125-007-0602-7
Golden, S. H., Wand, G. S., Malhotra, S., Kamel, I., & Horton, K. (2011). Reliability of hypothalamic-pituitary-adrenal axis assessment methods for use in population-based studies. European Journal of Epidemiology, 26, 511–525. https://doi.org/10.1007/s10654-011-9585-2
Hackett, R. A., Dal, Z., & Steptoe, A. (2020). The relationship between sleep problems and cortisol in people with type 2 diabetes. Psychoneuroendocrinology, 117, 104688.
Hackett, R. A., & Steptoe, A. (2017). Type 2 diabetes mellitus and psychological stress – A modifiable risk factor. Nature Reviews. Endocrinology, 13(9), 547–560.
Hagstrom, E. L., Patel, S., Karimkhani, C., et al. (2015). Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden. Journal of the American Academy of Dermatology, 73, 383–91.e1. https://doi.org/10.1016/j.jaad.2015.04.039
Hermanns, N., Caputo, S., Dzida, G., Khunti, K., Meneghini, L. F., & Snoek, F. (2013). Screening, evaluation and management of depression in people with diabetes in primary care. Primary Care Diabetes, 7, 1–10. https://doi.org/10.1016/j.pcd.2012.11.002
Hogan, P., Dall, T., & Nikolov, P. (2003). Economic costs of diabetes in the US in 2002. Diabetes Care, 26(3), 917–932.
Innes, K. E., & Selfe, T. K. (2016). Yoga for adults with type 2 diabetes: A systematic review of controlled trials. Journal Diabetes Research, 2016, 6979370.
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004). Increased risk of type 2 diabetes in Alzheimer disease. Diabetes, 53, 474–481.
Joëls, M., & Baram, T. Z. (2009). The neuro-symphony of stress. Nature Reviews. Neuroscience, 10(6), 459–466.
Kalra, S., Jena, B. N., & Yeravdekar, R. (2018). Emotional and psychological needs of people with diabetes. Indian Journal of Endocrinology and Metabolism, 22, 696–704. https://doi.org/10.4103/ijem.IJEM_579_17
Kanaya, A. M., Barrett-Connor, E., Gildengorin, G., & Yaffe, K. (2004). Change in cognitive function by glucose tolerance status in older adults: A 4-year prospective study of the rancho Bernardo study cohort. Archives of Internal Medicine, 164, 1327–1333.
Kaveeshwar, S. A., & Cornwall, J. (2014). The current state of diabetes mellitus in India. The Australasian Medical Journal, 7(1), 45–48.
Keezer, M. R., Novy, J., & Sander, J. W. (2015). Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: Prevalence and clinical characteristics. Epilepsy Research, 115, 55–57.
Kelly, S. J., & Ismail, M. (2015). Stress and type 2 diabetes: A review of how stress contributes to the development of type 2 diabetes. Annual Review of Public Health, 36(1), 441–462.
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., & Horwitz, R. I. (2002). Insulin resistance and risk for stroke. Neurology, 59, 809–815.
Koch, C. E., Leinweber, B., Drengberg, B. C., Blaum, C., & Oster, H. (2017). Interaction between circadian rhythms and stress. Neurobiol. Stress, SI: Stressors in animals, 6, 57–67.
Kodavanti, U. P. (2016). Stretching the stress boundary: Linking air pollution health effects to a neurohormonal stress response. Biochim. Biophys. Acta BBA - Gen. Subj., SI: Air Pollution, 1860, 2880–2890.
Kudielka, B. M., Hellhammer, D. H., & Wüst, S. (2009). Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology, 34(1), 2–18.
Kumar, B. M., Raja, T. K., Liaquathali, F., Maruthupandian, J., & Raja, P. V. (2021 Apr). A study on prevalence and factors associated with depression among elderly residing in tenements under resettlement scheme, Kancheepuram District, Tamil Nadu. Journal of Mid-Life Health, 12(2), 137.
Kyrou, I., & Tsigos, C. (2009). Stress hormones: Physiological stress and regulation of metabolism. Current Opinion in Pharmacology, 9, 787–793. https://doi.org/10.1016/j.coph.2009.08.007
Li, Y.-L., Chuang, T.-W., Chang, P.-y., Lin, L.-Y., Su, C.-T., Chien, L.-N., & Chiou, H.-Y. (2021). Long-term exposure to ozone and sulfur dioxide increases the incidence of type 2 diabetes mellitus among aged 30 to 50 adult population. Environmental Research, 194, 110624.
Liimatainen, S., Peltola, M., Sabater, L., Fallah, M., Kharazmi, E., Haapala, A. M., et al. (2010). Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia, 51(5), 760–767.
Liu, Z., Liu, J., Jahn, L. A., Fowler, D. E., & Barrett, E. J. (2009). Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. The Journal of Clinical Endocrinology and Metabolism, 94, 3543–3549. https://doi.org/10.1210/jc.2009-0027
Luchsinger, J. A., Tang, M. X., Shea, S., & Mayeux, R. (2004). Hyperinsulinemia and risk of Alzheimer disease. Neurology, 63, 1187–1192.
Maddatu, J., Anderson-Baucum, E., & Evans-Molina, C. (2017). Smoking and the risk of type 2 diabetes. Translational Research: The Journal of Laboratory and Clinical Medicine, 184, 101–107.
Madden, K. M. (2013). Evidence for the benefit of exercise therapy in patients with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 6(233), 39.
Manto, M. U., Laute, M. A., Aguera, M., Rogemond, V., Pandolfo, M., & Honnorat, J. (2007). Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Annals of Neurology, 61(6), 544–551.
Miller, D. B., Ghio, A. J., Karoly, E. D., Bell, L. N., Snow, S. J., Madden, M. C., Soukup, J., Cascio, W. E., Gilmour, M. I., & Kodavanti, U. P. (2016). Ozone exposure increases circulating stress hormones and lipid metabolites in humans. American Journal of Respiratory and Critical Care Medicine, 193(12), 1382–1391.
Mitchell, G. F., van Buchem, M. A., Sigurdsson, S., et al. (2011). Arterial stiffness, pressure and flow pulsatility and brain structure and function: The age, Gene/Environment Susceptibility--Reykjavik study. Brain, 134, 3398–3407. https://doi.org/10.1093/brain/awr253
Nordentoft, M., Rod, N. H., Bonde, J. P., Bjorner, J. B., Madsen, I. E. H., Pedersen, L. R. M., Cleal, B., Hanson, M., Linda, L., Nexo, M. A., Pentti, J., Stenholm, S., Sterud, T., Vahtera, J., & Rugulies, R. (2020). Effort-reward imbalance at work and risk of type 2 diabetes in a national sample of 50,552 workers in Denmark: A prospective study linking survey and register data. Journal of Psychosomatic Research, 128, 109867.
Olafsson, E., Ludvigsson, P., Gudmundsson, G., Hesdorffer, D., Kjartansson, O., & Hauser, W. A. (2005). Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: A prospective study. Lancet Neurology, 4, 627–634.
Ong, M. S., Kohane, I. S., Cai, T., Gorman, M. P., & Mandl, K. D. (2014). Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurology, 71(5), 569–574.
Oster, H. (2020). The interplay between stress, circadian clocks, and energy metabolism. The Journal of Endocrinology, 247, R13–R25.
Ozougwu, J., Obimba, K., Belonwu, C., & Unakalamba. (2013). The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. Journal of Physiology and Pathophysiology., 4(4), 46–57.
Patterson, Z. R., Khazall, R., Mackay, H., Anisman, H., & Abizaid, A. (2013). Central ghrelin signaling mediates the metabolic response of C57BL/6 male mice to chronic social defeat stress. Endocrinology, 154, 1080–1091. https://doi.org/10.1210/en.2012-1834
Pickup, J. C., & Crook, M. A. (1998). Is type II diabetes mellitus a disease of the innate immune system? Diabetologia, 41, 1241–1248. https://doi.org/10.1007/s001250051058
Raison, C. L., Capuron, L., & Miller, A. H. (2006). Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends in Immunology, 27, 24–31. https://doi.org/10.1016/j.it.2005.11.006
Ramakrishnan, R., & Appleton, R. (2012). Study of prevalence of epilepsy in children with type 1 diabetes mellitus. Seizure, 21, 292–294.
Renzi, M., Cerza, F., Gariazzo, C., Agabiti, N., Cascini, S., Di Domenicantonio, R., Davoli, M., Forastiere, F., & Cesaroni, G. (2018). Air pollution and occurrence of type 2 diabetes in a large cohort study. Environment International, 112, 68–76.
Romero, M. L., & Butler, L. K. (2007). Endocrinology of stress. International Journal of Comparative Psychology, 20, 89–95.
Sacks, D. B., Arnold, M., Bakris, G. L., et al. (2011). Guidelines and recommendations for laboratory analysis in the diagnosis and Management of Diabetes Mellitus. Clinical Chemistry, 57(6), e1 47.
Sapolsky, R. M. (2001). Depression, antidepressants, and the shrinking hippocampus. The Proceedings of the National Academy of Sciences U S A, 98, 12320–12322. https://doi.org/10.1073/pnas.231475998
Schwartz, S. S., Epstein, S., Corkey, B. E., Grant, S. F. A., Gavin, J. R., III, Aguilar, R. B., & Herman, M. E. (2017). A unified pathophysiological construct of diabetes and its complications. Trends in Endocrinology and Metabolism, 28, 645–655.
Slingerland, A. S., Shields, B. M., Flanagan, S. E., Bruining, G. J., Noordam, K., Gach, A., et al. (2009). Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia, 52(8), 1683–1685.
Snow, S. J., Henriquez, A. R., Costa, D. L., & Kodavanti, U. P. (2018). Neuroendocrine regulation of air pollution health effects: Emerging insights. Toxicological Sciences, 164, 9–20.
Stenvers, D. J., Scheer, F. A. J. L., Schrauwen, P., la Fleur, S. E., & Kalsbeek, A. (2019). Circadian clocks and insulin resistance. Nature Reviews. Endocrinology, 15(2), 75–89.
Steptoe, A., Hackett, R. A., Lazzarino, A. I., Bostock, S., La Marca, R., Carvalho, L. A., & Hamer, M. (2014). Disruption of multisystem responses to stress in type 2 diabetes: Investigating the dynamics of allostatic load. Proceedings of the National Academy of Sciences, 111(44), 15693–15698.
Stone, L. A., Harmatz, E. S., & Goosens, K. A. (2020). Ghrelin as a stress hormone: Implications for psychiatric illness. Biological Psychiatry, 88(7), 531–540.
Strodl, E., & Kenardy, J. (2006). Psychosocial and non-psychosocial risk factors for the new diagnosis of diabetes in elderly women. Diabetes Research and Clinical Practice, 74, 57–65. https://doi.org/10.1016/j.diabres.2006.02.011
Thomson, E. M. (2019). Air pollution, stress, and allostatic load: Linking systemic and central nervous system impacts. Journal of Alzheimer's Disease, 69(3), 597–614.
Ulrich-Lai, Y. M., & Herman, J. P. (2009). Neural regulation of endocrine and autonomic stress responses. Nature Reviews. Neuroscience, 10(6), 397–409.
Vetter, C., Dashti, H. S., Lane, J. M., Anderson, S. G., Schernhammer, E. S., Rutter, M. K., Saxena, R., & Scheer, F. A. J. L. (2018). Night shift work, genetic risk, and type 2 diabetes in the UK biobank. Diabetes Care, 41(4), 762–769.
Vincent, A., Bien, C. G., Irani, S. R., & Waters, P. (2011). Autoantibodies associated with diseases of the CNS: New developments and future challenges. Lancet Neurology, 10(8), 759–772.
Watkins, P. J., & Thomas, P. K. (1998 Nov 1). Diabetes mellitus and the nervous system. Journal of Neurology, Neurosurgery & Psychiatry., 65(5), 620–632.
Watson, G. S., & Craft, S. (2004). Modulation of memory by insulin and glucose: Neuropsychological observations in Alzheimer’s disease. European Journal of Pharmacology, 490, 97–113.
Weber, B., Schweiger, U., Deuschle, M., & Heuser, I. (2000). Major depression and impaired glucose tolerance. Experimental and Clinical Endocrinology and Diabetes, 108, 187–190. https://doi.org/10.1055/s-2000-7742
Whitaker, K. M., Everson-Rose, S. A., Pankow, J. S., Rodriguez, C. J., Lewis, T. T., Kershaw, K. N., Diez Roux, A. V., & Lutsey, P. L. (2017). Experiences of discrimination and incident type 2 diabetes mellitus: The multi-ethnic study of atherosclerosis (MESA). American Journal of Epidemiology, 186, 445–455.
Wright, R. J., & Schreier, H. M. C. (2013). Seeking an integrated approach to assessing stress mechanisms related to asthma. American Journal of Respiratory and Critical Care Medicine, 187(2), 115–116.
Yoshimoto, T., Doi, M., Fukai, N., Izumiyama, H., Wago, T., Minami, I., et al. (2005). Type 1 diabetes mellitus and drug-resistant epilepsy: Presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid. Internal Medicine, 44(11), 1174–1177.
Zänkert, S., Bellingrath, S., Wüst, S., & Kudielka, B. M. (2019). HPA axis responses to psychological challenge linking stress and disease: What do we know on sources of intra- and interindividual variability? Psychoneuroendocrinology, 105, 86–97.
Zimmet, P., Alberti, K. G., & Shaw, J. (2001). Global and societal implications of the diabetes epidemic. Nature, 414, 782–787.
Acknowledgments
The authors thank the Chettinad Academy of Research and Education for their constant support and encouragement.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kalarani, I.B., Veerabathiran, R. (2023). Diabetes and Neurological Disorder. In: Noor, R. (eds) Advances in Diabetes Research and Management. Springer, Singapore. https://doi.org/10.1007/978-981-19-0027-3_4
Download citation
DOI: https://doi.org/10.1007/978-981-19-0027-3_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-0026-6
Online ISBN: 978-981-19-0027-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)